ZA991029B - Composition and methods for treatment of hiv infections. - Google Patents

Composition and methods for treatment of hiv infections.

Info

Publication number
ZA991029B
ZA991029B ZA9901029A ZA991029A ZA991029B ZA 991029 B ZA991029 B ZA 991029B ZA 9901029 A ZA9901029 A ZA 9901029A ZA 991029 A ZA991029 A ZA 991029A ZA 991029 B ZA991029 B ZA 991029B
Authority
ZA
South Africa
Prior art keywords
inhibitor compounds
composition
treatment
methods
hiv infections
Prior art date
Application number
ZA9901029A
Other languages
English (en)
Inventor
Vassilios I Avramis
Lewis Cohen
Original Assignee
Rhone Poulenc Rorer Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Pharma filed Critical Rhone Poulenc Rorer Pharma
Publication of ZA991029B publication Critical patent/ZA991029B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA9901029A 1998-02-09 1999-02-09 Composition and methods for treatment of hiv infections. ZA991029B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7406698P 1998-02-09 1998-02-09

Publications (1)

Publication Number Publication Date
ZA991029B true ZA991029B (en) 1999-09-30

Family

ID=22117505

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901029A ZA991029B (en) 1998-02-09 1999-02-09 Composition and methods for treatment of hiv infections.

Country Status (10)

Country Link
EP (1) EP1053012B1 (xx)
JP (1) JP2002502826A (xx)
AT (1) ATE245444T1 (xx)
AU (1) AU752434B2 (xx)
CA (1) CA2319356A1 (xx)
DE (1) DE69909747T2 (xx)
DK (1) DK1053012T3 (xx)
ES (1) ES2203072T3 (xx)
WO (1) WO1999039732A1 (xx)
ZA (1) ZA991029B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2368230A1 (en) * 1999-04-02 2000-10-12 Children's Hospital Los Angeles Use of asparaginase and glutaminase to treat autoimmune disease and graft versus host disease
JP2003506409A (ja) * 1999-08-06 2003-02-18 アヴェンティス ファーマシューティカルズ インコーポレイテッド Ｈｉｖ感染の治療用組成物及び方法
CA2404737C (en) 2000-04-03 2010-06-29 Santen Pharmaceutical Co., Ltd. Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug
US6911460B2 (en) 2001-04-20 2005-06-28 Vion Pharmaceuticals, Inc. Antiviral agents and methods of treating viral infections
CN100536836C (zh) * 2002-11-26 2009-09-09 芝加哥大学 预防和治疗微生物介导的上皮紊乱的物质和方法
CA2574719A1 (en) * 2004-09-13 2006-03-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health Canada Inhibition of feline calicivirus replication by asparaginase
CN100475270C (zh) 2006-01-20 2009-04-08 清华大学 一种治疗肿瘤的药物及其应用
CN101002945B (zh) 2006-01-20 2012-09-05 清华大学 一种用于肿瘤治疗的新型复合物
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
CN101219219B (zh) 2007-01-10 2013-02-13 北京普罗吉生物科技发展有限公司 包含血管抑素或其片段的复合物、其制备方法及应用
WO2015033344A1 (en) * 2013-09-05 2015-03-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
MA51224A (fr) * 2017-11-29 2020-10-07 Taiho Pharmaceutical Co Ltd Composés de sulfonamide et leur utilisation
US20210299233A1 (en) 2018-07-12 2021-09-30 The Children's Medical Center Corporation Method for treating cancer
CN115671102A (zh) * 2022-11-17 2023-02-03 中国科学院大学 3-ap在制备抑制痘病毒的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600256B1 (fr) * 1986-06-19 1988-09-16 Inst Nat Sante Rech Med Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
AU752370B2 (en) * 1997-06-09 2002-09-19 Children's Hospital Of Los Angeles Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence

Also Published As

Publication number Publication date
CA2319356A1 (en) 1999-08-12
EP1053012B1 (en) 2003-07-23
ES2203072T3 (es) 2004-04-01
DK1053012T3 (da) 2003-11-17
DE69909747T2 (de) 2004-04-15
DE69909747D1 (de) 2003-08-28
JP2002502826A (ja) 2002-01-29
EP1053012A1 (en) 2000-11-22
ATE245444T1 (de) 2003-08-15
AU2658499A (en) 1999-08-23
WO1999039732A1 (en) 1999-08-12
AU752434B2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
TW200602350A (en) Methods and compositions for treating hepatitis C virus
DE60036961D1 (de) Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1-piperazinpentanamide als hiv-proteasehemmer
BR0111195A (pt) Uso de b-l-2'-desoxi-nucleosìdeos no tratamento de infecção por vìrus de hepatite delta
DK1293207T3 (da) Anvendelse af ritonavir (ABT-538) til forbedring af farmokokinetikken af lægemidler, som metaboliseres af cytochrome P450 i en fremgangsmåde til at behandle AIDS
UA42699C2 (uk) Бензоксазинонові сполуки, спосіб інгібування зворотної транскриптази, попередження або лікування, комбінації та фармацевтичні композиції
ZA991029B (en) Composition and methods for treatment of hiv infections.
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
ATE215952T1 (de) Hiv-proteaseinhibitoren
WO2001010454A3 (en) Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection
EE9700165A (et) Ühendite kombinatsioon, meetod ja farmatseutiline kompositsioon HIV proteaasi ja HIV pöördtranskriptaasi inhibeerimiseks ning HIV infektsiooni vältimiseks või raviks, või AIDS-i või ARC raviks
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
PL318506A1 (en) Combination of hiv protease inhibitors
WO2003093415A3 (en) Methods useful in treatment and prevention of hiv infection
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )
RU97104066A (ru) Сочетание ингибиторов вич-протеазы